Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Solid Tumor Immunotherapy Trial Using HLA-Haploidentical Transplant and Donor Natural Killer Cells: The STIR Trial

NCT02100891 is registered in ClinicalTrials.gov with Monica Thakar as lead sponsor.

NCT NCT02100891
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02100891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Solid Tumor Immunotherapy Trial Using HLA-Haploidentical Transplant and Donor Natural Killer Cells: The STIR Trial
Lead sponsor
Monica Thakar
Phase
Phase 2
Overall status
Terminated
Start date
March 20, 2013
Completion date
July 15, 2020
Enrollment
15 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cns tumors, ewing sarcoma, neuroblastoma, osteosarcoma, rhabdomyosarcoma